VALIDATED EXECUTIVE ENGAGEMENTS
POOL + OUTREACH
2183
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
393
Interactions with Platform & by Email
PARTICIPANTS
66
Unique # Participated
VALIDATIONS
31
Responses Validated*
* Login to view program details and full enterprise executive list.
DATE
SEP 2020
TABLES
108
PAGES
185
EDITION
19
PRICE
USD $5600
China Has Risen Into An Economic Powerhouse.
Find Out How You Can Leverage This Opportunity!
Amid the COVID-19 crisis, the global market for Mesenchymal Stem Cells (MSC) estimated at US$172.9 Million in the year 2020, is projected to reach a revised size of US$229 Million by 2027, growing at a CAGR of 4.1% over the analysis period 2020-2027. Human MSC, one of the segments analyzed in the report, is projected to record a 4.6% CAGR and reach US$94.8 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Mouse MSC segment is readjusted to a revised 4% CAGR for the next 7-year period.
The Mesenchymal Stem Cells (MSC) market in the U.S. is estimated at US$50.9 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$40.6 Million by the year 2027 trailing a CAGR of 3.9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.8% and 3.4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.
In the global Rat MSC segment, USA, Canada, Japan, China and Europe will drive the 3.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$27.7 Million in the year 2020 will reach a projected size of US$36.2 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$25.5 Million by the year 2027.We bring years of research experience to this 19th edition of our report. The 185-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Cell Applications Inc.; Celprogen Inc.; Cyagen US Inc.; Genlantis Inc.; Lonza Group; Mesoblast Limited; MilliporeSigma; Neuromics; Orthofix International N.V.; PromoCell GmbH; R&D Systems Inc.; ScienCell Research Laboratories; Stemcell Technologies Inc.; Stemedica Cell Technologies Inc.; Thermo Fischer Scientific Inc.
» Type (Human MSC, Mouse MSC, Rat MSC, Other Types) » Application (Research Institutes, Hospitals, Other Applications)
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
INSIDER ACCESS PRIVILEGES
Users of our portal have insider access to our data stacks based on project relevance and engagement status. Tiered access is offered to data stacks, managed based on user status - Opt-in, Active Panelist, Inactive Panelist, Active Client or Inactive Client.
KEY DIFFERENTIATORS
We are firmly committed to build upon perspectives from global executive insights. These engagements enrich our projects. Our primary research programs are fully validated and accessible by clients. (Its a common industry-wide* practice that no validated primary research is done! For the most part, remote resident analysts curate and write reports drawing on search engine research and data modeling.
* A review of 262 off-the-shelf market report publishers worldwide.
WHAT SETS US APART
Client companies can access multiple features on our MarketGlass™ platform.
Clients have full-stack insider access to our ongoing primary research program. We have a very successful incentive driven primary research program that benefits participating executives regardless of their purchase decision. Our platform presents a unique opportunity to collaborate with peers and review competitors’ inputs and response clusters.
Detailed engagement stats are presented for every company and executive contacted. This is made available for our client reviews. (no other publisher offers this!)
A full-stack access to clients of all primary and secondary source content. This can often run into thousands of pages.
Where relevent and possible we present competitive brands.
Peer-to-peer online interactive collaborations. Allows for team curated bespoke analytics.
Customers can update and build bespoke versions of our analytics. Bespoke updates are fulfilled within a two-day turnaround.
Discretely bounce off queries to participant pool of executives. Our embedded AI selectively pings participants geographically and by domain acumen.
We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.
Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.
All updates are offered for one year from date of your purchase without charge. Clients can opt for annual auto renewal and stay current without interruption.
05
| I. INTRODUCTION, METHODOLOGY & REPORT SCOPE |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Mesenchymal Stem Cells Market on a Rapid Growth Path |
| Recent Market Activity |
| Current and Future Analysis |
| The Present and Future of MSC Therapies |
| Select MSC-based Therapeutics |
| Mesenchymal Stem Cell Research |
| Completed Phase III Studies with MSCs |
| MSCs are Being Explored for Several New Treatment Possibilities |
| Widespread Commercialization of 'Off-the-Shelf' MSCs to Become a Reality |
| Software Companies Endeavour to Cash in on the Boom |
| Global Competitor Market Shares |
| Mesenchymal Stem Cells (MSC) Competitor Market Share Scenario Worldwide (in %): 2018 & 2029 |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| Cell Applications, Inc. (USA) |
| Celprogen, Inc. (USA) |
| Cyagen US Inc. (USA) |
| Genlantis, Inc. (USA) |
| Lonza Group (Switzerland) |
| Mesoblast Limited (Australia) |
| MilliporeSigma (USA) |
| Neuromics (USA) |
| Orthofix International N.V. (Italy) |
| PromoCell GmbH (Germany) |
| R&D Systems, Inc. (USA) |
| ScienCell Research Laboratories (USA) |
| Stemcell Technologies Inc. (Canada) |
| Stemedica Cell Technologies, Inc. (USA) |
| Thermo Fischer Scientific, Inc. (USA) |
| Vitro Biopharma (USA) |
| 3. MARKET TRENDS & DRIVERS |
| Development of Regenerative Medicine Accelerates Demand for MSCs |
| Ageing Demographics to Drive Demand for Mesenchymal Stem Cell Therapies |
| Global Aging Population Statistics - Opportunity Indicators |
| Growing Prevalence of Chronic Diseases Propels Demand for Mesenchymal Stem Cells |
| Key Disease Statistics - Opportunity Indicators |
| Growing Volume of Orthopedic Procedures: An Opportunity for the MSC Market |
| Adult Stem Cell Therapies on Growth Trajectory, as Controversies Continue to Haunt Embryonic Stem Cell Research |
| Adult Stem Cells and Embryonic Stem Cells - A Comparison |
| MSCs Versus Embryonic or Induced Pluripotent Stem Cells |
| MSC Therapies - Immune to Ethical Issues Applicable to Embryonic Stem Cells |
| MSCs - A Potential Vehicle for 'Targeted Drug Delivery' |
| Stem Cell Based Bone Grafts: Promising Growth Ahead |
| Loopholes Associated with In Vivo Properties Constrain Therapeutic Advancements |
| Major Challenges Confronting Mesenchymal Stem Cell Market |
| Allogeneic MSCs - Offering Promise in Immunosuppressive and Tissue Repair Therapy |
| Administration Route Determines the Effectiveness of MSCs |
| 4. GLOBAL MARKET PERSPECTIVE |
| Mesenchymal Stem Cells (MSC) Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018-2025 |
| Mesenchymal Stem Cells (MSC) Global Retrospective Market Scenario in US$ Thousand by Region/Country: 2009-2017 |
| Mesenchymal Stem Cells (MSC) Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025 |
| Human MSC (Type) World Market by Region/Country in US$ Thousand: 2018 to 2025 |
| Human MSC (Type) Historic Market Analysis by Region/Country in US$ Thousand: 2009 to 2017 |
| Human MSC (Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025 |
| Mouse MSC (Type) Potential Growth Markets Worldwide in US$ Thousand: 2018 to 2025 |
| Mouse MSC (Type) Historic Market Perspective by Region/Country in US$ Thousand: 2009 to 2017 |
| Mouse MSC (Type) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025 |
| Rat MSC (Type) Geographic Market Spread Worldwide in US$ Thousand: 2018 to 2025 |
| Rat MSC (Type) Region Wise Breakdown of Global Historic Demand in US$ Thousand: 2009 to 2017 |
| Rat MSC (Type) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025 |
| Other Types (Type) World Market Estimates and Forecasts by Region/Country in US$ Thousand: 2018 to 2025 |
| Other Types (Type) Market Historic Review by Region/Country in US$ Thousand: 2009 to 2017 |
| Other Types (Type) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025 |
| Research Institutes (Application) Worldwide Latent Demand Forecasts in US$ Thousand by Region/Country: 2018-2025 |
| Research Institutes (Application) Global Historic Analysis in US$ Thousand by Region/Country: 2009-2017 |
| Research Institutes (Application) Distribution of Global Sales by Region/Country: 2009 VS 2019 VS 2025 |
| Hospitals (Application) Sales Estimates and Forecasts in US$ Thousand by Region/Country for the Years 2018 through 2025 |
| Hospitals (Application) Analysis of Historic Sales in US$ Thousand by Region/Country for the Years 2009 to 2017 |
| Hospitals (Application) Global Market Share Distribution by Region/Country for 2009, 2019, and 2025 |
| Other Applications (Application) Global Opportunity Assessment in US$ Thousand by Region/Country: 2018-2025 |
| Other Applications (Application) Historic Sales Analysis in US$ Thousand by Region/Country: 2009-2017 |
| Other Applications (Application) Percentage Share Breakdown of Global Sales by Region/Country: 2009 VS 2019 VS 2025 |
| III. MARKET ANALYSIS |
| GEOGRAPHIC MARKET ANALYSIS |
| United States |
| Market Facts & Figures |
| US Mesenchymal Stem Cells (MSC) Market Share (in %) by Company: 2018 & 2025 |
| United States Mesenchymal Stem Cells (MSC) Market Estimates and Projections in US$ Thousand by Type: 2018 to 2025 |
| Mesenchymal Stem Cells (MSC) Market in the United States by Type: A Historic Review in US$ Thousand for 2009-2017 |
| United States Mesenchymal Stem Cells (MSC) Market Share Breakdown by Type: 2009 VS 2019 VS 2025 |
| United States Mesenchymal Stem Cells (MSC) Latent Demand Forecasts in US$ Thousand by Application: 2018 to 2025 |
| Mesenchymal Stem Cells (MSC) Historic Demand Patterns in the United States by Application in US$ Thousand for 2009-2017 |
| Mesenchymal Stem Cells (MSC) Market Share Breakdown in the United States by Application: 2009 VS 2019 VS 2025 |
| Canada |
| Canadian Mesenchymal Stem Cells (MSC) Market Estimates and Forecasts in US$ Thousand by Type: 2018 to 2025 |
| Canadian Mesenchymal Stem Cells (MSC) Historic Market Review by Type in US$ Thousand: 2009-2017 |
| Mesenchymal Stem Cells (MSC) Market in Canada: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025 |
| Canadian Mesenchymal Stem Cells (MSC) Market Quantitative Demand Analysis in US$ Thousand by Application: 2018 to 2025 |
| Mesenchymal Stem Cells (MSC) Market in Canada: Summarization of Historic Demand Patterns in US$ Thousand by Application for 2009-2017 |
| Canadian Mesenchymal Stem Cells (MSC) Market Share Analysis by Application: 2009 VS 2019 VS 2025 |
| Japan |
| Japanese Market for Mesenchymal Stem Cells (MSC): Annual Sales Estimates and Projections in US$ Thousand by Type for the Period 2018-2025 |
| Mesenchymal Stem Cells (MSC) Market in Japan: Historic Sales Analysis in US$ Thousand by Type for the Period 2009-2017 |
| Japanese Mesenchymal Stem Cells (MSC) Market Share Analysis by Type: 2009 VS 2019 VS 2025 |
| Japanese Demand Estimates and Forecasts for Mesenchymal Stem Cells (MSC) in US$ Thousand by Application: 2018 to 2025 |
| Japanese Mesenchymal Stem Cells (MSC) Market in US$ Thousand by Application: 2009-2017 |
| Mesenchymal Stem Cells (MSC) Market Share Shift in Japan by Application: 2009 VS 2019 VS 2025 |
| China |
| Chinese Mesenchymal Stem Cells (MSC) Market Growth Prospects in US$ Thousand by Type for the Period 2018-2025 |
| Mesenchymal Stem Cells (MSC) Historic Market Analysis in China in US$ Thousand by Type: 2009-2017 |
| Chinese Mesenchymal Stem Cells (MSC) Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
| Chinese Demand for Mesenchymal Stem Cells (MSC) in US$ Thousand by Application: 2018 to 2025 |
| Mesenchymal Stem Cells (MSC) Market Review in China in US$ Thousand by Application: 2009-2017 |
| Chinese Mesenchymal Stem Cells (MSC) Market Share Breakdown by Application: 2009 VS 2019 VS 2025 |
| Europe |
| Market Facts & Figures |
| European Mesenchymal Stem Cells (MSC) Market: Competitor Market Share Scenario (in %) for 2018 & 2025 |
| European Mesenchymal Stem Cells (MSC) Market Demand Scenario in US$ Thousand by Region/Country: 2018-2025 |
| Mesenchymal Stem Cells (MSC) Market in Europe: A Historic Market Perspective in US$ Thousand by Region/Country for the Period 2009-2017 |
| European Mesenchymal Stem Cells (MSC) Market Share Shift by Region/Country: 2009 VS 2019 VS 2025 |
| European Mesenchymal Stem Cells (MSC) Market Estimates and Forecasts in US$ Thousand by Type: 2018-2025 |
| Mesenchymal Stem Cells (MSC) Market in Europe in US$ Thousand by Type: A Historic Review for the Period 2009-2017 |
| European Mesenchymal Stem Cells (MSC) Market Share Breakdown by Type: 2009 VS 2019 VS 2025 |
| European Mesenchymal Stem Cells (MSC) Addressable Market Opportunity in US$ Thousand by Application: 2018-2025 |
| Mesenchymal Stem Cells (MSC) Market in Europe: Summarization of Historic Demand in US$ Thousand by Application for the Period 2009-2017 |
| European Mesenchymal Stem Cells (MSC) Market Share Analysis by Application: 2009 VS 2019 VS 2025 |
| France |
| Mesenchymal Stem Cells (MSC) Market in France by Type: Estimates and Projections in US$ Thousand for the Period 2018-2025 |
| French Mesenchymal Stem Cells (MSC) Historic Market Scenario in US$ Thousand by Type: 2009-2017 |
| French Mesenchymal Stem Cells (MSC) Market Share Analysis by Type: 2009 VS 2019 VS 2025 |
| Mesenchymal Stem Cells (MSC) Quantitative Demand Analysis in France in US$ Thousand by Application: 2018-2025 |
| French Mesenchymal Stem Cells (MSC) Historic Market Review in US$ Thousand by Application: 2009-2017 |
| French Mesenchymal Stem Cells (MSC) Market Share Analysis: A 17-Year Perspective by Application for 2009, 2019, and 2025 |
| Germany |
| Mesenchymal Stem Cells (MSC) Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Type for the Period 2018-2025 |
| German Mesenchymal Stem Cells (MSC) Historic Market Analysis in US$ Thousand by Type: 2009-2017 |
| German Mesenchymal Stem Cells (MSC) Market Share Breakdown by Type: 2009 VS 2019 VS 2025 |
| Mesenchymal Stem Cells (MSC) Market in Germany: Annual Sales Estimates and Forecasts in US$ Thousand by Application for the Period 2018-2025 |
| German Mesenchymal Stem Cells (MSC) Market in Retrospect in US$ Thousand by Application: 2009-2017 |
| Mesenchymal Stem Cells (MSC) Market Share Distribution in Germany by Application: 2009 VS 2019 VS 2025 |
| Italy |
| Italian Mesenchymal Stem Cells (MSC) Market Growth Prospects in US$ Thousand by Type for the Period 2018-2025 |
| Mesenchymal Stem Cells (MSC) Historic Market Analysis in Italy in US$ Thousand by Type: 2009-2017 |
| Italian Mesenchymal Stem Cells (MSC) Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025 |
| Italian Demand for Mesenchymal Stem Cells (MSC) in US$ Thousand by Application: 2018 to 2025 |
| Mesenchymal Stem Cells (MSC) Market Review in Italy in US$ Thousand by Application: 2009-2017 |
| Italian Mesenchymal Stem Cells (MSC) Market Share Breakdown by Application: 2009 VS 2019 VS 2025 |
| United Kingdom |
| United Kingdom Market for Mesenchymal Stem Cells (MSC): Annual Sales Estimates and Projections in US$ Thousand by Type for the Period 2018-2025 |
| Mesenchymal Stem Cells (MSC) Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Type for the Period 2009-2017 |
| United Kingdom Mesenchymal Stem Cells (MSC) Market Share Analysis by Type: 2009 VS 2019 VS 2025 |
| United Kingdom Demand Estimates and Forecasts for Mesenchymal Stem Cells (MSC) in US$ Thousand by Application: 2018 to 2025 |
| United Kingdom Mesenchymal Stem Cells (MSC) Market in US$ Thousand by Application: 2009-2017 |
| Mesenchymal Stem Cells (MSC) Market Share Shift in the United Kingdom by Application: 2009 VS 2019 VS 2025 |
| Rest of Europe |
| Rest of Europe Mesenchymal Stem Cells (MSC) Market Estimates and Forecasts in US$ Thousand by Type: 2018-2025 |
| Mesenchymal Stem Cells (MSC) Market in Rest of Europe in US$ Thousand by Type: A Historic Review for the Period 2009-2017 |
| Rest of Europe Mesenchymal Stem Cells (MSC) Market Share Breakdown by Type: 2009 VS 2019 VS 2025 |
| Rest of Europe Mesenchymal Stem Cells (MSC) Addressable Market Opportunity in US$ Thousand by Application: 2018-2025 |
| Mesenchymal Stem Cells (MSC) Market in Rest of Europe: Summarization of Historic Demand in US$ Thousand by Application for the Period 2009-2017 |
| Rest of Europe Mesenchymal Stem Cells (MSC) Market Share Analysis by Application: 2009 VS 2019 VS 2025 |
| Asia-Pacific |
| Mesenchymal Stem Cells (MSC) Market in Asia-Pacific by Type: Estimates and Projections in US$ Thousand for the Period 2018-2025 |
| Asia-Pacific Mesenchymal Stem Cells (MSC) Historic Market Scenario in US$ Thousand by Type: 2009-2017 |
| Asia-Pacific Mesenchymal Stem Cells (MSC) Market Share Analysis by Type: 2009 VS 2019 VS 2025 |
| Mesenchymal Stem Cells (MSC) Quantitative Demand Analysis in Asia-Pacific in US$ Thousand by Application: 2018-2025 |
| Asia-Pacific Mesenchymal Stem Cells (MSC) Historic Market Review in US$ Thousand by Application: 2009-2017 |
| Asia-Pacific Mesenchymal Stem Cells (MSC) Market Share Analysis: A 17-Year Perspective by Application for 2009, 2019, and 2025 |
| Rest of World |
| Rest of World Mesenchymal Stem Cells (MSC) Market Estimates and Forecasts in US$ Thousand by Type: 2018 to 2025 |
| Rest of World Mesenchymal Stem Cells (MSC) Historic Market Review by Type in US$ Thousand: 2009-2017 |
| Mesenchymal Stem Cells (MSC) Market in Rest of World: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025 |
| Rest of World Mesenchymal Stem Cells (MSC) Market Quantitative Demand Analysis in US$ Thousand by Application: 2018 to 2025 |
| Mesenchymal Stem Cells (MSC) Market in Rest of World: Summarization of Historic Demand Patterns in US$ Thousand by Application for 2009-2017 |
| Rest of World Mesenchymal Stem Cells (MSC) Market Share Analysis by Application: 2009 VS 2019 VS 2025 |
| IV. COMPETITION |
| Total Companies Profiled : 47 Click here to request a full table of contents and more details on this project. |
INSIDER ACCESS TO
METHODOLOGY
QUESTIONNAIRE
INFLUENCER NETWORK
Registration is required to access our data stacks.
RESEARCH PANEL
Panelists are carefully chosen based on their domain expertise and market influence.
Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.
Our panelists give 30-minutes a month or a one-time 30-minute participation based on their time and willingness.
- Complimentary previews of full stack research data for participated
- Insider access to research programs including engagements and stats from other panelists
- Unlimited research credits of $1000 per participated project
- Competitive Intelligence Alerts including engagements from other panelists and validated participants worldwide relevant to your company
- Interact with other panelists via our MarketGlassTM Data Exchange Platform*
- BlogX - Panelists can use our blogging platform publish their viewpoints on news relevant to their domain expertise. Platform enables panelists to share their viewpoints on current news and events related to their areas domain expertise with timely and insightful blogs*
* Complete details will be shared with panelists upon formal acceptance.
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com